Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ayurvedic treatment may improve quality of life for cancer patients undergoing chemo and radiotherapy.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Targeted protein degradation could improve cancer treatment by effectively targeting the Wnt pathway.

Azelaic acid treats acne, rosacea, and hyperpigmentation with minimal side effects.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

St. John's wort skin oil may increase skin damage risk during radiotherapy.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Compounds from Etlingera alba may help treat Triple Negative Breast Cancer.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Analog 23 is a promising compound for prostate cancer treatment.

Young cancer survivors need better information on wigs and hair regrowth.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.